Clinical trials · New York
Pulmonary Embolism clinical trials in New York
We’re tracking 9 recruiting pulmonary embolism studies with a site in New York — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT06672510Recruiting
Study of a clot-removal device for acute pulmonary embolism
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
New York, New YorkAges 18 years+ - NCT06433011Recruiting
New clot-busting method for pulmonary embolism
This study tests a new way of delivering a clot-dissolving medicine for people with a serious but not immediately life-threatening pulmonary embolism. The goal is to see if giving the medicine as small bursts directly into the clot can help the heart recover faster.
Liverpool, New YorkAges Any age - NCT06784492Recruiting
Healthy living tips after a pulmonary embolism
This study tests whether healthy living tips and messages sent daily by text or email can help you recover better after a serious blood clot in your lung called a pulmonary embolism. It may be a good fit if you are already taking a blood thinner and can receive text messages.
Rochester, New YorkAges 18 years+ - NCT06041594Recruiting
Treating pulmonary embolism with the Laguna thrombectomy system
This trial tests a device (Laguna Thrombectomy System) to remove blood clots in the lungs. It may help people with a recent pulmonary embolism who are stable enough to undergo a minimally invasive procedure.
Albany, New YorkAges 18–85 - NCT04798261Recruiting
Long-term follow-up after clot removal for pulmonary embolism
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
New York, New YorkAges 18 years+ - NCT05591118RecruitingPhase 3
Catheter treatment to remove blood clots in the lungs
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
New York, New YorkAges 18 years+ - NCT07280247Recruiting
AlphaVac System for Treating Acute Pulmonary Embolism
This study tests a device that suctions blood clots from the lungs in people with a moderate-risk pulmonary embolism. The goal is to see if it is safe and effective at removing clots and improving blood flow.
The Bronx, New YorkAges 18 years+ - NCT06588634Recruiting
A study of a catheter device for high-risk pulmonary embolism
This trial tests a new treatment for people with a severe, high-risk pulmonary embolism (blood clot in the lung). It uses a catheter device to remove the clot and help the heart work better.
Bay Shore, New YorkAges 18 years+ - NCT07350499Recruiting
Using Symphony or Prodigy to remove blood clots
This study tests how well the Symphony or Prodigy system works for removing blood clots from arteries or veins. You may qualify if you are 18 or older and scheduled for a procedure that uses one of these devices.
Buffalo, New YorkAges 18 years+
Pulmonary Embolism trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting pulmonary embolism studies listed above.
- Mount Sinai Hospital · 2 studies
- University at Buffalo · 2 studies
- Albany Medical Center
- Bellevue Hospital Center
- Columbia University Irving Medical Center
- Cumc/Nyph
- Icahn School of Medicine at Mount Sinai
- Jacobi Medical Center
What taking part in a pulmonary embolism study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Pulmonary Embolism trials in other states
Common questions
- Are there pulmonary embolism clinical trials in New York?
- Yes. We're currently tracking 9 recruiting pulmonary embolism studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a pulmonary embolism study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a pulmonary embolism trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New pulmonary embolism studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.